Abstract
Because of the neuro-autonomic remodeling with increased vagal tone, trained athletes commonly develop benign rhythm and conduction disturbances including sinus bradycardia, junctional rhythm, first-degree and second-degree Mobitz type-I atrioventricular block, that disappear with adrenergic stimulation during exercise and do not preclude sports participation. Paroxysmal supraventricular tachycardia and atrial fibrillation usually occur in athletes with a structurally normal heart but may be incompatible with competitive sports activity in case of severe symptoms or exercise-dependent episodes. On the other hand, ventricular arrhythmias ranging from isolated premature ventricular beats to ventricular tachycardia require careful clinical investigation aiming to exclude an underlying structural heart disease potentially at risk of sudden cardiac death before the athlete can safely engage in high-intensity exercise.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blake JB, Larrabee RC. Observations upon long distance runners. Boston Med Surg J. 1903;148:195.
Chapman JH. Profound sinus bradycardia in the athletic heart syndrome. J Sports Med Phys Fitness. 1982;22:45–8.
Hanne-Paparo N, Kellermann JJ. Long-term Holter ECG monitoring of athletes. Med Sci Sports Exerc. 1981;13:294–8.
Zehender M, Meinertz T, Keul J, et al. ECG variants and cardiac arrhythmia in athletes: clinical relevance and prognostic importance. Am Heart J. 1990;119:1378–91.
Huston TP, Puffer JC, Rodney WM. The athletic heart syndrome. N Engl J Med. 1985;313:24–32.
Viitasalo MT, Kala R, Eisalo A. Ambulatory electrocardiographic findings in young athletes between 14 and 16 years of age. Eur Heart J. 1984;5:2–6.
Palatini P, Maraglino G, Sperti G, et al. Prevalence and possible mechanisms of ventricular arrhythmias in athletes. Am Heart J. 1985;110:560–7.
Talan DA, Bauernfeind RA, Ashley WW, et al. Twentyfour hour continuous ECG recordings in longdistance runners. Chest. 1982;82:19–24.
Viitasalo M, Kala R, Eisalo A. Ambulatory electrocardiographic recording in endurance athletes. Br Heart J. 1982;47:213–20.
Meytes I, Kaplinsky E, Yahini JH. Wenckebach A-V block: a frequent feature following heavy physical training. Am Heart J. 1975;90:426–30.
Zeppilli P, Fenici R, Sassara M, et al. Wenckebach second-degree AV block in top-ranking athletes: an old problem revisited. Am Heart J. 1980;100:291–4.
Vidal A, Agorrody V, Abreu R, et al. Vagally third-degree AV block in a highly trained endurance athlete. Europace. 2017;19:1863.
Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. Heart Rhythm. 2016;13:e136–221.
Sarubbi B. The Wolff-Parkinson-White electrocardiogram pattern in athletes: how and when to evaluate the risk for dangerous arrhythmias. The opinion of the paediatric cardiologist. J Cardiovasc Med (Hagerstown). 2006;7:271–8.
Biffi A, Delise P, Zeppilli P, et al. Italian cardiological guidelines for sports eligibility in athletes with heart disease: part 1. J Cardiovasc Med. 2013;14:500–15.
Karjalainen J, Kujala UM, Kaprio J, et al. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ. 1998;316:1784–5.
Mont L, Sambola A, Brugada J, et al. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J. 2002;23:477–82.
Elosua R, Arquer A, Mont L, et al. Sport practice and the risk of lone atrial fibrillation: a case-control study. Int J Cardiol. 2006;108:332–7.
Molina L, Mont L, Marrugat J, et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace. 2008;10:618–23.
Masia R, Pena A, Marrugat J, et al. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health. 1998;52:707–15.
Mont L, Tamborero D, Elosua R, GIRAFA (Grup Integrat de Recerca en Fibril-lació Auricular) Investigators, et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace. 2008;10:15–20.
Myrstad M, Løchen ML, Graff-Iversen S, et al. Increased risk of atrial fibrillation among elderly Norwegian men with a history of long-term endurance sport practice. Scand J Med Sci Sports. 2014;24:e238–44.
Heidbuchel H, Anné W, Willems R, et al. Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutter. Int J Cardiol. 2006;107:67–72.
D'Ascenzi F, Cameli M, Ciccone MM, et al. The controversial relationship between exercise and atrial fibrillation: clinical studies and pathophysiological mechanisms. J Cardiovasc Med (Hagerstown). 2015;16:802–10.
Pelliccia A, Maron BJ, Di Paolo FM, et al. Prevalence and clinical significance of left atrial remodeling in competitive atheletes. J Am Coll Cardiol. 2005;46:690–5.
Woodward A, Tin Tin S, Doughty RN, Ameratunga S. Atrial fibrillation and cycling: six year follow-up of the Taupo bicycle study. BMC Public Health. 2015;15:23.
Kwok CS, Anderson SG, Myint PK, Mamas MA, Loke YK. Physical activity and incidence of atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2014;177:467–76.
Hoogsteen J, Schep G, Van Hemel NM, et al. Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up. Europace. 2004;6:222–8.
Sarceviz Z, Tepavcecic A. Competitive endurance activities of middle-aged athletes as a risk factor for atrial fibrillation. Curr Sports Med Rep. 2018;17:391–5.
Zipes DP, Link MS, Ackerman MJ, Kovacs RJ, Myerburg RJ, Estes NA 3rd. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e315–25.
Lai E, Chung EH. Management of arrhythmias in athletes: atrial fibrillation, premature ventricular contractions, and ventricular tachycardia. Curr Treat Options Cardiovasc Med. 2017;19:86.
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609–78.
Furlanello F, Lupo P, Pittalis M, et al. Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition. J Cardiovasc Electrophysiol. 2008;19:457–62.
Calvo N, Mont L, Tamborero D, Berruezo A, Viola G, Guasch E, Nadal M, Andreu D, Vidal B, Sitges M, Brugada J. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace. 2010;12:30–6.
Koopman P, Nuyens D, Garweg C, La Gerche A, De Buck S, Van Casteren L, Alzand B, Willems R, Heidbuchel H. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace. 2011;13:1386–93.
Corrado D, Zorzi A. Risk of catheter ablation for atrial fibrillation. JACC Clin Electrophysiol. 2017;3:1434–6.
Schmieder S, Ndrepepa G, Dong J, Zrenner B, Schreieck J, Schneider MA, Karch MR, Schmitt C. Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation. Eur Heart J. 2003;24:956–62.
Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002;40:446–52.
Jacobson JT, Iwai S, Aronow W. Medical therapy to prevent recurrence of ventricular arrhythmia in normal and structural heart disease patients. Expert Rev Cardiovasc Ther. 2016;14:1251–62.
Delise P, Sitta N, Lanari E, et al. Long-term effect of continuing sports activity in competitive athletes with frequent ventricular premature complexes and apparently normal heart. Am J Cardiol. 2013;112:1396–402.
D’Ascenzi F, Zorzi A, Alvino F, et al. The prevalence of premature ventricular beats in the athlete. Scand J Med Sci Sports. 2017;27:140–51.
Steriotis AK, Nava A, Rigato I, et al. Noninvasive cardiac screening in young athletes with ventricular arrhythmias. Am J Cardiol. 2013;111:557–62.
Verdile L, Maron BJ, Pelliccia A, et al. Clinical significance of exercise-induced ventricular tachyarrhythmias in trained athletes without cardiovascular abnormalities. Heart Rhythm. 2015;12:78–85.
Rahilly GT, Prystowsky EN, Zipes DP, et al. Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram. Am J Cardiol. 1982;50:459–68.
Buxton AE, Marchlinski FE, Doherty JU, et al. Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease. Am J Cardiol. 1984;54:997–1002.
Zorzi A, De Lazzari M, Mastella G, Niero A, Trovato D, Cipriani A, et al. Ventricular arrhythmias in young competitive athletes: prevalence, determinants, and underlying substrate. J Am Heart Assoc. 2018;7(12):e009171.
Zorzi A, Mastella G, Cipriani A, Berton G, Del Monte A, Gusella B, et al. Burden of ventricular arrhythmias at 12-lead 24-hour ambulatory ECG monitoring in middle-aged endurance athletes versus sedentary controls. Eur J Prev Cardiol. 2018;25:2003–11.
Cipriani A, Zorzi A, Sarto P, Donini M, Rigato I, Bariani R, et al. Predictive value of exercise testing in athletes with ventricular ectopy evaluated by cardiac magnetic resonance. Heart Rhythm. 2019;16:239–48.
Zorzi A, Perazzolo Marra M, Rigato I, De Lazzari M, Susana A, Niero A, et al. Nonischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes. Circ Arrhythm Electrophysiol. 2016;9(7):e004229.
Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106(1):69–74.
Heidbuchel H, Corrado D, Biffi A, et al. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil. 2006;13(5):676–86.
Comitato organizzativo cardiologico per l’idoneità allo sport (COCIS). Protocolli cardiologici per il giudizio di idoneità allo sport agonistico. Italy: C.E.S.I. ed. Roma; 2017.
John RM, Stevenson WG. Outflow tract premature ventricular contractions and ventricular tachycardia: the typical and the challenging. Card Electrophysiol Clin. 2016;8:545–54.
Sung R, Scheinman M. Spectrum of fascicular arrhythmias. Card Electrophysiol Clin. 2016;8(3):567–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Review
Review
1.1 Questions
-
1.
Top-level athlete, male, 28 years old, practicing soccer from 15 years, asymptomatic, without family and personal history for cardiovascular disease, presenting with a second-degree, type 1 atrio-ventricular block during resting 12-lead ECG. What examination may be useful to guarantee his sport eligibility?
-
2.
Volleyball player, male, 27 years old, without clinical history of sudden death, asymptomatic, during pre-participation screening; occurrence of exercise-induced ventricular arrhythmias during an exercise stress test, sometimes as couplets, with RBBB morphology and wide QRS complex. What further examinations do you suggest?
-
3.
24 years old, male tennis player , presenting with paroxysmal palpitations and resting ECG showing a supraventricular tachycardia at HR 220 bpm, with narrow and regular QRS. The tachycardia has a spontaneous interruption after 10 min. When sinus rhythm is restored, ECG shows the presence of an overt ventricular pre-excitation. Can the athlete be considered eligible for competitive sports activity at this point?
1.2 Answers
-
1.
Exercise stress testing (EST) is the first exam to confirm the physiological, adaptive response of atrio-ventricular node to exercise training. EST usually normalizes the atrio-ventricular conduction during exercise and recovery phase. Also 24-h Holter ECG monitoring, including a training session, could be useful to verify the normalization of AV conduction during an exercise session and to show the maximal expression of AV disturbances during night sleeping.
-
2.
The arrhythmia morphology (RBBB with wide QRS) is uncommon and could be associated with a concealed arrhythmogenic substrate, such as left ventricular scar. Therefore, beyond carrying out colour-doppler echocardiogram and 24-h Holter ECG monitoring, also contrast enhanced cardiac magnetic resonance, with tissue imaging typing, is requested.
-
3.
No. Symptomatic WPW syndrome is not compatible with competitive sports activity. The athlete can be considered suitable for RF catheter ablation.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Biffi, A., Zorzi, A., Corrado, D. (2020). Specific Cardiovascular Diseases and Competitive Sports Participation: Arrhythmias. In: Pressler, A., Niebauer, J. (eds) Textbook of Sports and Exercise Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-35374-2_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-35374-2_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-35373-5
Online ISBN: 978-3-030-35374-2
eBook Packages: MedicineMedicine (R0)